跳至主要内容
临床试验/ITMCTR2100005233
ITMCTR2100005233尚未招募1 期

Clinical evaluation study of pricking blood therapy based on Xuanfu theory in the treatment of chronic urticaria

Hebei University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1. Those who meet the diagnostic criteria of chronic urticaria in the EAACI/GA2LEN/EDF/WAO guidelines for the treatment of urticaria (2017) and the Chinese guidelines for the treatment of urticaria (2018);
  • 2. Aged 18-70 years;
  • 3. No antihistamines use within 2 weeks before enrollment and no steroids or immunosuppressive drugs within 1 month;
  • 4. The liver and kidney functions are normal;
  • 5. Not participating in other ongoing clinical studies;
  • 6. Voluntary participation and signed informed consent form.

排除标准

  • 1. Unconscious people who cannot express subjective symptoms of discomfort and psychiatric patients;
  • 2. Those with Progressive malignant tumors or other serious wasting diseases, who are prone to co-infection and bleeding;
  • 3. Patients with severe primary diseases such as cardiovascular, liver, kidney, digestion, hematopoietic system;
  • 4. Pregnant and lactating women.

研究者

发起方
Hebei University of Chinese Medicine

相似试验

Pricking blood therapy for chronic urticaria: a... | 临床试验